Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Spain Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20044
20061
20073
20082
20091
20105
20113
20122
20133
20163
20174
20201
20211
20221
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated5
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen-Cilag International NV5
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Janssen Research & Development, LLC3
ACADIA Pharmaceuticals Inc.2
AstraZeneca2
Boehringer Ingelheim2
Denovo Biopharma LLC2
Eli Lilly and Company2
FORUM Pharmaceuticals Inc2
H. Lundbeck A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia39
Psychotic Disorders4
Autistic Disorder2
Cognition Disorders2
Bipolar Disorder1
Cognitive Dysfunction1
Recurrence1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.